Disruption of GPR35 Signaling in Bone Marrow-Derived Cells Does Not Influence Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice
Authors:
- Roland BaumgartnerRBRoland Baumgartner
- Felipe B. CasagrandeFCFelipe B. Casagrande
- Randi B. MikkelsenRMRandi B. Mikkelsen
- Martin BergMBMartin Berg
- Konstantinos A. PolyzosKPKonstantinos A. Polyzos
- Maria J. FortezaMFMaria J. Forteza
- Aastha AroraAAAastha Arora
- Thue W. SchwartzTSThue W. Schwartz
- Siv A. HjorthSHSiv A. Hjorth
- Daniel F. J. KetelhuthDKDaniel F. J. Ketelhuth
Open Access
- 23 June 2021
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 11 (7) , 411
Abstract
G-protein-coupled receptor-35 (GPR35) has been identified as a receptor for the tryptophan metabolite kynurenic acid (KynA) and suggested to modulate macrophage polarization in metabolic tissues. Whether GPR35 can influence vascular inflammation and atherosclerosis has however never been tested. Lethally irradiated LdlrKO mice were randomized to receive GPR35KO or wild type (WT) bone marrow transplants and fed a high cholesterol diet for eight weeks to develop atherosclerosis. GPR35KO and WT chimeric mice presented no difference in the size of atherosclerotic lesions in the aortic arch (2.37 ± 0.58% vs. 1.95 ± 0.46%, respectively) or in the aortic roots (14.77 ± 3.33% vs. 11.57 ± 2.49%, respectively). In line with these data, no changes in the percentage of VCAM-1+, IAb + cells, and CD3+ T cells, as well as alpha smooth muscle cell actin expression, was observed between groups. Interestingly, the GPR35KO group presented a small but significant increase in CD68+ macrophage infiltration in the plaque. However, in vitro culture experiments using bone marrow-derived macrophages from both groups indicated that GPR35 plays no role in modulating the secretion of major inflammatory cytokines. Our study indicates that GPR35 expression does not play a direct role in macrophage activation, vascular inflammation, and the development of atherosclerosis.Keywords
Funding Information
- Swedish Heart-Lung Foundation (-)
- Novo Nordisk Fonden (NNF15CC0018346)
- Syddansk Universitet (-)
This publication has 21 references indexed in Scilit:
- Lysophosphatidic Acid-Mediated GPR35 Signaling in CX3CR1+ Macrophages Regulates Intestinal HomeostasisCell Reports, 2020
- Immunometabolism and atherosclerosis: perspectives and clinical significance: a position paper from the Working Group on Atherosclerosis and Vascular Biology of the European Society of CardiologyCardiovascular Research, 2019
- Disruption of GPR35 Exacerbates Dextran Sulfate Sodium-Induced Colitis in MiceDigestive Diseases and Sciences, 2018
- GPCR-Mediated Signaling of MetabolitesCell Metabolism, 2017
- The Antiallergic Mast Cell Stabilizers Lodoxamide and Bufrolin as the First High and Equipotent Agonists of Human and Rat GPR35Molecular Pharmacology, 2014
- G-Protein-Coupled Receptor 35 Is a Target of the Asthma Drugs Cromolyn Disodium and Nedocromil SodiumPharmacology, 2010
- Global and regional causes of deathBritish Medical Bulletin, 2009
- Expression analysis of G Protein-Coupled Receptors in mouse macrophagesImmunome Research, 2008
- Subendothelial Lipoprotein Retention as the Initiating Process in AtherosclerosisCirculation, 2007
- Kynurenic Acid as a Ligand for Orphan G Protein-coupled Receptor GPR35Journal of Biological Chemistry, 2006